Format

Send to

Choose Destination
CMAJ. 2017 May 8;189(18):E659-E666. doi: 10.1503/cmaj.170363.

Guideline for opioid therapy and chronic noncancer pain.

Author information

1
The Michael G. DeGroote Institute for Pain Research and Care (Busse, Buckley, Couban, Craigie and Wang), Department of Anesthesia (Busse and Buckley), Department of Health Research Methods, Evidence, and Impact (Busse, Carrasco-Labra, Iorio and Guyatt), McMaster University, Hamilton, Ont.; University Hospitals of Geneva (Agoritsas), Geneva, Switzerland; American University of Beirut (Akl), Beirut, Lebanon; Canadian Pain Coalition (Cooper), Oshawa, Ont.; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry (Carrasco-Labra), University of Chile, Santiago, Chile; Inspire by Example, Canada (Cull); Institute of Primary Health Care (da Costa), University of Bern, Bern, Switzerland; VA Eastern Colorado Health Care System (Frank), Denver, Colo. and University of Colorado School of Medicine (Frank), Aurora, Colo.; College of Physicians and Surgeons of Nova Scotia (Grant), Halifax, NS; Departments of Medicine and Pediatrics (Juurlink), University of Toronto, Toronto, Ont.; Li Ka Shing Knowledge Institute (Persaud), St. Michael's Hospital, Toronto, Ont.; Argus Medical Centre (Stern), Oakville, Ont.; Department of Medicine (Tugwell), University of Ottawa, Ottawa, Ont.; Innlandet Hospital Trust-Division Gjøvik (Vandvik), Norway bussejw@mcmaster.ca.
2
The Michael G. DeGroote Institute for Pain Research and Care (Busse, Buckley, Couban, Craigie and Wang), Department of Anesthesia (Busse and Buckley), Department of Health Research Methods, Evidence, and Impact (Busse, Carrasco-Labra, Iorio and Guyatt), McMaster University, Hamilton, Ont.; University Hospitals of Geneva (Agoritsas), Geneva, Switzerland; American University of Beirut (Akl), Beirut, Lebanon; Canadian Pain Coalition (Cooper), Oshawa, Ont.; Department of Oral and Maxillofacial Surgery, Faculty of Dentistry (Carrasco-Labra), University of Chile, Santiago, Chile; Inspire by Example, Canada (Cull); Institute of Primary Health Care (da Costa), University of Bern, Bern, Switzerland; VA Eastern Colorado Health Care System (Frank), Denver, Colo. and University of Colorado School of Medicine (Frank), Aurora, Colo.; College of Physicians and Surgeons of Nova Scotia (Grant), Halifax, NS; Departments of Medicine and Pediatrics (Juurlink), University of Toronto, Toronto, Ont.; Li Ka Shing Knowledge Institute (Persaud), St. Michael's Hospital, Toronto, Ont.; Argus Medical Centre (Stern), Oakville, Ont.; Department of Medicine (Tugwell), University of Ottawa, Ottawa, Ont.; Innlandet Hospital Trust-Division Gjøvik (Vandvik), Norway.
PMID:
28483845
PMCID:
PMC5422149
DOI:
10.1503/cmaj.170363
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

Competing interests: D. Norm Buckley and Jason Busse report grants from Health Canada during the conduct of the study. Jason Busse received grants from the Canadian Institutes of Health Research (CIHR) during the conduct of the study. D. Norm Buckley reports grants from Purdue Pharma and Janssen Inc. outside the submitted work. Chris Cull received personal fees from Indivior. David Juurlink reports grants from CIHR and from the Ontario Ministry of Health and Long-Term Care, and personal fees outside the submitted work. Sol Stern was a member of advisory boards for Astra Zeneca, Bristol-Myers Squibb and Johnson and Johnson; received fees for expert opinions from the Canadian Medical Protective Association; received consulting fees from mdBriefCase.com, Ethypharm and Sea Courses; and received honoraria for Continuing Medical Education presentations from Purdue Pharma and Paladin. No other competing interests were declared.

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center